Improving Heart Failure Care in Minority Communities

Sponsor
Icahn School of Medicine at Mount Sinai (Other)
Overall Status
Completed
CT.gov ID
NCT00211874
Collaborator
Agency for Healthcare Research and Quality (AHRQ) (U.S. Fed)
406
4
2
24
101.5
4.2

Study Details

Study Description

Brief Summary

For congestive heart failure (CHF) patients with systolic dysfunction, a randomized controlled trial compared nurse-based disease management to address problems in patient and clinician management with usual care for effects on hospitalization and functioning among ethnically-diverse patients in ambulatory practices.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Nurse-management
N/A

Detailed Description

Congestive heart failure (CHF) disproportionately afflicts Black and elderly people, and is a leading cause of hospitalization > 65 years. Although effective therapies can improve functioning and survival in patients with systolic dysfunction, many may not be receiving the full benefit of existing knowledge, including counseling on self-management and appropriate doses of medications. Patients play a critical role in managing a chronic condition such as CHF, but may not have the skills to do so. Clinicians may not provide counseling or medications consistent with evidence-based guidelines.

Systematic reviews of clinical-behavior change have suggested that interventions targeted to specific problems are more likely to be successful. Based on shortfalls identified in patient self-management and clinical care in Harlem, a predominately non-white area in northern Manhattan, we tailored a nurse-management intervention to address the problems documented, and evaluated its effectiveness in a randomized controlled trial. This trial among primarily-minority patients addresses important gaps in this literature: the study targeted problems documented among CHF patients in Harlem, enrolled patients from ambulatory practices, randomly assigned patients between nurse-management and usual care, and evaluated their subsequent health-related outcomes. Hypothesis: the nurse-management program would result in nurse patients' having fewer hospitalizations and reporting better functioning.

Study Design

Study Type:
Interventional
Actual Enrollment :
406 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
Improving Heart Failure Care in Minority Communities
Study Start Date :
Sep 1, 2000
Actual Primary Completion Date :
Sep 1, 2002
Actual Study Completion Date :
Sep 1, 2002

Arms and Interventions

Arm Intervention/Treatment
Experimental: Nurse-management

nurse-led intervention focused on specific management problems

Behavioral: Nurse-management
bilingual nurses counseled patients on diet, medication adherence, and self-management of symptoms through an initial visit and regularly scheduled follow-up telephone calls and facilitated evidence-based changes to medications in discussions with patients' clinicians.
Other Names:
  • Nurse-based disease management
  • No Intervention: Usual Care

    Usual care as control group

    Outcome Measures

    Primary Outcome Measures

    1. Short Form 12 questionnaire [12 months]

      self-reported physical functioning as measured by the physical component score on the Short Form 12 questionnaire

    Secondary Outcome Measures

    1. Number of hospitalizations [12 months]

      number of hospitalizations in 12 month period

    2. Minnesota Living with Heart Failure Questionnaire [12 months]

      self-reported physical functioning as measured by the physical component score on the Minnesota Living with Heart Failure Questionnaire

    3. Number of deaths [12 months]

      deaths measured by the reporting of death by patient family or recording in the National Death Index

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • • adults >18 years,

    • systolic dysfunction documented on a cardiac test (echocardiography, radionuclide ventriculography, myocardial stress sestamibi/thallium testing, or left-heart catheterization),

    • English- or Spanish-speaking,

    • community-dwelling at enrollment, and

    • current patient in a general medicine, geriatrics, or cardiology clinic or office at a participating site.

    Exclusion Criteria:
    • • medical conditions that prevented a patient's interacting with the nurse, including blindness, deafness, and cognitive impairment;

    • medical conditions that required individualized management that might differ from standard protocol, namely pregnancy, renal dialysis, and terminal illness; and

    • procedures that corrected systolic dysfunction, such as heart transplantation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mount Sinai School of Medicine New York New York United States 10029-6574
    2 Metropolitan Hospital New York New York United States 10029
    3 North General Hospital New York New York United States 10035
    4 Harlem Hospital New York New York United States 10037

    Sponsors and Collaborators

    • Icahn School of Medicine at Mount Sinai
    • Agency for Healthcare Research and Quality (AHRQ)

    Investigators

    • Principal Investigator: Jane Sisk, Ph.D., Icahn School of Medicine at Mount Sinai
    • Principal Investigator: Paul Hebert, MD, Icahn School of Medicine at Mount Sinai

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Icahn School of Medicine at Mount Sinai
    ClinicalTrials.gov Identifier:
    NCT00211874
    Other Study ID Numbers:
    • GCO 99-0347
    • AHRQ R01 HS10402-01
    First Posted:
    Sep 21, 2005
    Last Update Posted:
    Oct 12, 2015
    Last Verified:
    Oct 1, 2015
    Keywords provided by Icahn School of Medicine at Mount Sinai
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 12, 2015